Tubulin beta 3 class III mRNA 3' untranslated region (TUBB3 mRNA 3' UTR)

The Tubulin beta 3 class III (TUBB3) mRNA 3' untranslated region (UTR) is a regulatory sequence within the TUBB3 transcript that governs the expression of the beta-III tubulin protein [NCBI Gene: 10381]. This protein is a key component of microtubules, typically restricted to neurons but frequently aberrantly expressed in various solid tumors [UniProt: Q13509]. The 3' UTR serves as a docking site for microRNAs, such as the miR-200 family, and RNA-binding proteins that modulate mRNA stability and translation [PubMed: 20406990]. In clinical oncology, high levels of TUBB3 are a well-documented biomarker for resistance to taxane-based chemotherapies, as the protein provides alternative microtubule pathways that bypass drug-induced stabilization [PubMed: 11507054]. Consequently, the TUBB3 mRNA 3' UTR is an attractive target for RNA-targeted therapies, including antisense oligonucleotides (ASOs) and microRNA mimics, designed to silence TUBB3 expression and restore drug sensitivity [PubMed: 23536445]. Beyond its role in cancer, dysregulation or mutations affecting TUBB3 are implicated in complex cortical malformations and ocular motility disorders like CFEOM3 [PubMed: 20074521]. Therapeutic development targeting this region must carefully balance the need for potent knockdown in tumor cells with the risk of neurotoxicity due to the protein's essential role in the nervous system.

Other names

TUBB3 3' UTRClass III beta-tubulin mRNA 3' untranslated regionTUBB3 3'-UTRTubulin beta-3 chain mRNA 3' UTR

Antisense inhibition or RNA interference targeting the 3' UTR to induce mRNA degradation or translational repression, thereby reducing TUBB3 protein levels.